Kinetics of procalcitonin in iatrogenic sepsis [1]

Intensive Care Medicine

Volumn 24, Issue 8, 1998, Pages 888-889

  Brunkhorst, F M ^a   Heinz, U ^a   Forycki, Z F ^a  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; HEMODIALYSIS FLUID; OXACILLIN; OXYGEN; PIPERACILLIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACINETOBACTER BAUMANNII; AGED; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLOOD; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CASE REPORT; CATTLE; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HUMAN; IATROGENIC DISEASE; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; INTRAVENOUS ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LETTER; LEUKOCYTOSIS; LEUKOPENIA; MYALGIA; PERIPHERAL CIRCULATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RESTLESSNESS; TACHYCARDIA; VERTIGO;

EID: 0031707475     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050683     Document Type: Letter

References (5)

1. 1. M Assicot D Gendrel H Carsin J Raymond J Guilbaud C Bohoun 1993 High serum procalcitonin in patients with sepsis and infection Lancet 341 515 518 8094770 10.1016/0140-6736(93)90277-N 1:STN:280:ByyC2s3otV0%3D Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohoun C (1993) High serum procalcitonin in patients with sepsis and infection. Lancet 341: 515–518
2. 2. OK Eberhard M Haubitz FM Brunkhorst V Kliem KM Koch F Brunkhorst 1997 Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection Arthritis Rheum 40 1250 1257 9214425 1:STN:280:ByiA2MjgslA%3D Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst F (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40:1250–1257
3. 3. HB Reith P Lehmkuhl W Beier 1995 Procalcitonin — ein prognostischer Infektionsparameter bei der Peritonitis Chir Gastroenterol 11 Suppl 2 47 50 Reith HB, Lehmkuhl P, Beier W et al. (1995) Procalcitonin — ein prognostischer Infektionsparameter bei der Peritonitis. Chir Gastroenterol 11 (Suppl 2): 47–50
4. 4. D Gendrel M Assicot J Raymond 1996 Procalcitonin as a marker for the early diagnosis of neonatal infection J Pediatr 128 570 573 8618197 10.1016/S0022-3476(96)70374-8 1:STN:280:BymC1cnhtFQ%3D Gendrel D, Assicot M, Raymond J et al. (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128: 570–573
5. 5. P Dandona D Nix MF Wilson 1994 Procalcitonin increase after endotoxin injection in normal subjects J Clin Endocrinol Metab 79 5 1605 1608 7989463 10.1210/jc.79.6.1605 1:CAS:528:DyaK2MXislWitLg%3D Dandona P, Nix D, Wilson MF et al. (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79 (5): 1605–1608